| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |